Sharp Therapeutics Corp.
Research Sharp Therapeutics Corp. (SHRX) on Bullrun: market cap CAD 27.37M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSHRX
- ExchangeV
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 27.37M
- Financial periodFY2025
- RevenueUSD 0
- Net income-USD 6.17M
- Free cash flow-USD 4.83M
Valuation Snapshot
latest market cap is CAD 27.37M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 6.17M | -USD 4.83M | n/a | n/a | USD 956.60K | USD 1.28M | -USD 176.60K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | CAD 27.37M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Sharp Therapeutics Corp.
Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sharp Therapeutics Corp.'s market cap?
Sharp Therapeutics Corp.'s market capitalization is CAD 27.37M.
What does Sharp Therapeutics Corp. do?
Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a custom-built, cloud-distributed analytics platform that captures data for AlloChem compounds in CoreX assays. Sharp Therapeutics Corp.